While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading to an early diagnosis of essential thrombocythemia. Despite initial ...
Stocktwits on MSN
Galecto Stock Surges Premarket After Damora Acquisition — Retail Bulls Predict Another Massive Rally
Galecto announced the acquisition of Damora Therapeutics and a $285 million private raise backed by major biotech investors, ...
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential ...
Hemorrhagic events post-diagnosis in patients with ET significantly increase mortality risk, more than thrombosis or disease progression. Intracranial hemorrhage is the most lethal bleeding ...
Galecto stock jumps after acquiring Damora Therapeutics and raising $285 million to advance blood cancer programs through ...
Patients with essential thrombocythemia faced an average delay of 26.5 months between their first high platelet count and diagnosis. Patients experienced a significant delay in receiving an essential ...
PURPOSE: To examine the utility of polycythemia rubra vera-1 (PRV-1)–specific reverse transcriptase polymerase chain reaction (RT-PCR) to discriminate essential thrombocythemia (ET) and polycythemi ...
Essential thrombocythaemia is a clonal myeloproliferative neoplasm associated with a lifelong risk of arterial and venous ...
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study The Oncology Grand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback